.png)
.png)
BIA/VWR Day - Defining the Biotech Lab of the Future
VWR International and the BIA invite you to our Networking and Workshop Event in Cambridge on 21 March 2018. We hope that you will join us for this excellent opportunity to share experiences, and observe some best practice from the experts - as well as connecting with a wide range of industry specialists. Free to attend.
Discussion panels on the day will include:
- The Cambridge Infrastructure Challenge
- Brexit and the Modern Industrial Strategy
- Evolution of manufacturing of Advanced Therapies
- Talent challenges at the interface of biology and technology
Speakers will include:
- Tarquin Bennett-Coles, Global Talent Scout, Innovative Medicines and Early Development (iMED), AstraZeneca
- Maria Ferguson, Director of Human Resources, Cambridge Epigenetix
- Richard Hammond, Technology Director, Cambridge Consultants
- Dr Sabine Jaccaud, Director, Cambridge Communications, AstraZeneca
- Eric Johnsson, Policy and Public Affairs Executive, BIA
- Derek Jones, Chief Executive, Babraham Research Campus
- Dr Jim Mills, Senior Vice President - Technical Operations, Abzena
- Rob Sadler, Director, Savills
- Dr Martin Turner, Policy and Projects Manager, BIA
Download the delegate invite for more information
This free of charge event will include:
- Overview of industry trends
- An day of workshops with BIA and other organisations
- Networking lunch
- Dinner hosted by VWR. Guest speaker will be Steve Bates, Chief Executive Officer, BIA
- Discounted local accommodation
- Breakfast with BIA the following day. You must register seperately for this event.
- Plenty of networking opportunities and exchange of insight and ideas throughout both days
King's Hedges Room
The Cambridge Building
Babraham
Babraham Research Campus
Cambridge
CB22 3AT
United Kingdom
Tamburlaine Hotel
27-29 Station Rd
Cambridge
CB1 2FB
Private dining in Cambridge, 15 minute drive from Babraham
Tarquin Bennett-Coles
Tarquin Bennett-Coles is a Global Talent Scout, Innovative Medicines and Early Development (iMED) at AstraZeneca based in Cambridge. He has two decades of life science executive search and interim management experience and before moving in-house to join AstraZeneca and MedImmune worked in partnership with international biopharma companies, NGO’s (CEPI), university spin-outs and rare and orphan disease SMEs. He has handled complex assignments across research and development, drug discovery, competitive intelligence, analytics, medical and clinical functions, commercial leadership, C-Suite and board positions. In addition he has partnered with relevant industry associations, the VC community and the not-for-profit sector. He is a regular contributor to industry journals, recently chaired the Talent Gap at the Gap Summit, has chaired and spoken at BioIndustry Association events and was an invited panellist on the One Nucleus’s Building Successful Teams discussion at the Innovation Forum Leaders Conference. Tarquin has been a guest lecturer on the prestigious Masters in Bioscience Enterprise programme since 2008. Tarquin is a STEM (Science, Technology, Engineering, Maths) and SIP (Science Industry Partnership) Ambassador and has a Bachelors in Education honours degree from the University of Cambridge.
Maria Ferguson
Maria is a senior executive with extensive experience of working within FTSE 100 and NASDAQ publicly quoted companies and within private equity portfolio businesses. Maria has an MBA and has developed a portfolio career that spans a number of market-sectors including banking, media, logistics and retail. Maria brings to CEGX a wealth of knowledge and pragmatism of delivering strategies and people plans for growth and diversification.
Richard Hammond
Richard is Technology Director and Head of Synthetic Biology at Cambridge Consultants. Richard has twenty years' experience in design and development of products and processes for the healthcare and life-sciences industries. His particular interest is how new ideas and techniques in manipulating and modifying biological systems are translated into widely-available products and therapies. Prior to joining Cambridge Consultants, Richard worked for Alere Inc. where he was responsible for development of the Alere i infectious disease diagnostic platform. Richard holds BA, MA and MEng degrees from the University of Cambridge.
Eric Johnsson
Eric joined the BIA in March 2017. Previously he worked for the NHS in patient confidentiality and data protection. As a student, in Australia and Scotland, he held part-time positions in legal and parliamentary research. Originally from Sweden, Eric holds a 1st Class Masters degree in International Economic Law from the University of Edinburgh and a Bachelor of Arts in Politics and International Relations from Murdoch University in Australia. In his spare time, Eric enjoys the martial art of Brazilian Jiu-Jitsu and travelling to warm and sunny locations.
Derek Jones
Derek brings a wealth of experience to the Babraham Research Campus: over 25 years in the life science industry as both a scientist and in business development and corporate development, with first-hand experience of establishing biomedical ventures. Initially a medicinal chemist at Merck, Derek moved into business and corporate development at Chiroscience, successfully negotiating and managing several multi-million pound licensing agreements, including being part of the team that licensed the UK’s first biotech product, Chirocaine. In 2000, he co-founded his first company, BioWisdom, an IT/Drug discovery company. Derek was appointed COO at DanioLabs in 2002, a therapeutics company using zebrafish as a model for drug discovery, where he grew the company from 4 to 34 employees and raised around £10 million for VC backed companies, before selling DanioLabs for £15 million in 2007. He joined Babraham in 2008 as Chief Business Officer with responsibility for the knowledge exchange and commercialisation (KEC) of the Babraham Institute’s IP portfolio. During that time he spun out Crescendo Biologics, focussed around IP from the Babraham Institute. Derek has been a member of the Babraham Research Campus board since 2008 and became CEO in 2010. Following restructuring of the business in 2013, Babraham Research Campus Ltd’s primary focus has been on the development and management of the campus, with KEC responsibilities returning to the Babraham Institute.
Rob Sadler
Savills is a truly multidisciplinary real estate advisor employing in excess of 30,000 real estate experts in over 700 offices and Associates throughout the globe. This depth and breadth of expertise means that you can be assured of a highly responsive, quality service, where you need it. Our strength is our people and we are committing to attracting developing and motivating the best in the business. The calibre of our personnel is something of which we are most proud and we have assembled a team which will deliver the things that matter most to you. Savills is currently taking forward some of the UK’s newest and largest life science developments. Our integrated in-house team includes strategists, market analysts, specialist designers, master planners and technical specialists together with the UK’s leading investment, brand and marketing specialists. In addition, we undertake market analysis and monitor national and international best practice trends. Rob is Head of Office for Cambridge and Head of Commercial for the Eastern Region with over 18 years’ experience in the commercial property field, including all aspects of commercial development, agency, professional valuations and corporate consultancy. Rob specialises in Business Space development and Life Science. Rob joined Savills in 2005 and became a Director in March 2009.
BIA Annual Supporters
